| pubmed-article:21515903 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C0023185 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C0013421 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C0221099 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C1519249 | lld:lifeskim |
| pubmed-article:21515903 | lifeskim:mentions | umls-concept:C1742737 | lld:lifeskim |
| pubmed-article:21515903 | pubmed:issue | Pt 5 | lld:pubmed |
| pubmed-article:21515903 | pubmed:dateCreated | 2011-5-20 | lld:pubmed |
| pubmed-article:21515903 | pubmed:abstractText | Abnormalities in motor sequence learning have been observed in non-manifesting carriers of the DYT1 dystonia mutation. Indeed, motor sequence learning deficits in these subjects have been associated with increased cerebellar activation during task performance. In the current study, we determined whether similar changes are also present in clinically manifesting DYT1 carriers as well as in carriers of other primary dystonia mutations such as DYT6. Additionally, we determined whether sequence learning performance and associated brain activation in these subjects correlate with previously described genotype-related abnormalities of cerebellar pathway integrity and striatal D2 dopamine receptor binding. Nineteen DYT1 carriers (10 non-manifesting DYT1: 51.5±15.1 years; nine manifesting DYT1: 46.1±15.1 years) and 12 healthy control subjects (42.8±15.3 years) were scanned with H2(15)O positron emission tomography while performing controlled sequence learning and reference tasks. Eleven DYT6 carriers (four non-manifesting DYT6: 38.0±22.1; seven manifesting DYT6: 35.3±14.2 years) were evaluated during task performance without concurrent imaging. DYT1 and DYT6 carriers also underwent diffusion tensor magnetic resonance imaging for the assessment of tract integrity and 11C-raclopride positron emission tomography to measure caudate/putamen D2 receptor binding. These imaging measures were correlated with sequence learning performance and associated activation responses. Sequence learning deficits of similar magnitude were observed in manifesting and non-manifesting DYT1 carriers. In contrast, learning deficits were not detected in DYT6 carriers, irrespective of clinical penetrance. Affected DYT1 carriers exhibited significant increases in sequence learning-related activation in the left lateral cerebellar cortex and in the right premotor and inferior parietal regions. Increases in premotor cortical activation observed in the mutation carriers correlated with reductions in cerebellar pathway integrity measured using magnetic resonance diffusion tensor imaging and probabilistic tractography. Additionally, the cerebellar tract changes correlated with reductions in dentate nucleus activation recorded during task performance. Sequence learning performance and task-related activation responses did not correlate with striatal D2 receptor binding. In summary, we found that sequence learning deficits and concomitant increases in cerebellar activation are specific features of the DYT1 genotype. The close relationship between reduced cerebellar pathway integrity and increased learning-related activation of the premotor cortex is compatible with the view of DYT1 dystonia as a neurodevelopmental circuit disorder. | lld:pubmed |
| pubmed-article:21515903 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21515903 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21515903 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21515903 | pubmed:month | May | lld:pubmed |
| pubmed-article:21515903 | pubmed:issn | 1460-2156 | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:BressmanSusan... | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:EidelbergDavi... | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:DhawanVijayV | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:MattisPaulP | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:CarbonMarenM | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:GhilardiMaria... | lld:pubmed |
| pubmed-article:21515903 | pubmed:author | pubmed-author:ArgyelanMiklo... | lld:pubmed |
| pubmed-article:21515903 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21515903 | pubmed:volume | 134 | lld:pubmed |
| pubmed-article:21515903 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21515903 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21515903 | pubmed:pagination | 1416-27 | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:meshHeading | pubmed-meshheading:21515903... | lld:pubmed |
| pubmed-article:21515903 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21515903 | pubmed:articleTitle | Impaired sequence learning in dystonia mutation carriers: a genotypic effect. | lld:pubmed |
| pubmed-article:21515903 | pubmed:affiliation | Centre for Neurosciences, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, New York 11030, USA. marencarbon@hotmail.com | lld:pubmed |
| pubmed-article:21515903 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21515903 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:1861 | entrezgene:pubmed | pubmed-article:21515903 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21515903 | lld:entrezgene |
